Target Healthcare REIT PLC
LSE:THRL

Watchlist Manager
Target Healthcare REIT PLC Logo
Target Healthcare REIT PLC
LSE:THRL
Watchlist
Price: 101 GBX 2.12% Market Closed
Market Cap: 626.4m GBX
Section:
 

Relative Value

The Relative Value of one THRL stock under the Base Case scenario is 118.96 GBX. Compared to the current market price of 101 GBX, Target Healthcare REIT PLC is Undervalued by 15%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

THRL Relative Value
Base Case
118.96 GBX
Undervaluation 15%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

8.6
P/S
P/S
Price to Sales
8.6
vs History
39
vs Industry
21
Median 3Y
7.5
Median 5Y
8.2
Industry
3.8
Forward
9.1
More Details
10.3
P/E
P/E
Price to Earnings
10.3
vs History
39
vs Industry
47
Median 3Y
7.7
Median 5Y
9.6
Industry
16.3
Forward
16.2
More Details
15.2
P/OCF
P/OCF
Price to OCF
15.2
vs History
39
vs Industry
28
Median 3Y
13.8
Median 5Y
14.7
Industry
11.2
More Details
20.9
P/FCFE
P/FCFE
Price to FCFE
20.9
vs History
15
vs Industry
25
Median 3Y
19.5
Median 5Y
10.7
Industry
12.8
More Details
0.9
P/B
P/B
Price to Book Value
0.9
vs History
39
vs Industry
44
Median 3Y
0.8
Median 5Y
0.8
Industry
0.9
More Details
10.1
EV/S
EV/S
Enterprise Value to Sales
10.1
vs History
63
vs Industry
26
Median 3Y
9.9
Median 5Y
10.6
Industry
6.8
Forward
10.7
More Details
10.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
10.1
vs History
31
vs Industry
48
Median 3Y
9.7
Median 5Y
9.7
Industry
12.5
More Details
12.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
12.3
vs History
61
vs Industry
46
Median 3Y
12
Median 5Y
12.8
Industry
15.9
Forward
13.7
More Details
12.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
12.3
vs History
61
vs Industry
49
Median 3Y
12
Median 5Y
12.8
Industry
19.2
Forward
13.7
More Details
17.9
EV/OCF
EV/OCF
Enterprise Value to OCF
17.9
vs History
53
vs Industry
37
Median 3Y
17.4
Median 5Y
18.4
Industry
18.5
More Details
17.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
17.9
vs History
53
vs Industry
34
Median 3Y
17.4
Median 5Y
18.4
Industry
20.7
More Details
0.8
EV/IC
EV/IC
Enterprise Value to IC
0.8
vs History
60
vs Industry
35
Median 3Y
0.8
Median 5Y
0.8
Industry
0.8
More Details

Multiples Across Competitors

THRL Competitors Multiples
Target Healthcare REIT PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Target Healthcare REIT PLC
LSE:THRL
626.4m GBP 8.6 10.3 12.3 12.3
US
Welltower Inc
NYSE:WELL
127.7B USD 12.9 132.9 37.8 84.8
US
Ventas Inc
NYSE:VTR
35.6B USD 6.4 149.4 21.2 51.8
US
Omega Healthcare Investors Inc
NYSE:OHI
13.4B USD 11.6 25.6 17 24.5
US
Physicians Realty Trust
NYSE:DOC
11.7B USD 4.2 -300 13.1 40.7
US
Healthpeak Properties Inc
F:HC5
10B EUR 4.2 -300.2 13.1 40.7
US
CareTrust REIT Inc
NYSE:CTRE
8.3B USD 19.3 31.8 23.2 29.8
US
Healthcare Trust Of America Inc
F:HT01
5.3B EUR 8 65.8 20 51.4
US
Healthcare Realty Trust Inc
NYSE:HR
5.9B USD 4.9 -16 16 171.2
US
Sabra Health Care REIT Inc
NASDAQ:SBRA
4.9B USD 6.6 28 16.4 27.4
BE
Aedifica NV
XBRU:AED
3.5B EUR 9.7 15.3 19 19.2
P/E Multiple
Earnings Growth PEG
UK
Target Healthcare REIT PLC
LSE:THRL
Average P/E: 57.4
10.3
-10%
N/A
US
Welltower Inc
NYSE:WELL
132.9
29%
4.6
US
Ventas Inc
NYSE:VTR
149.4
79%
1.9
US
Omega Healthcare Investors Inc
NYSE:OHI
25.6
12%
2.1
US
Physicians Realty Trust
NYSE:DOC
Negative Multiple: -300
-7%
N/A
US
H
Healthpeak Properties Inc
F:HC5
Negative Multiple: -300.2
-7%
N/A
US
C
CareTrust REIT Inc
NYSE:CTRE
31.8
44%
0.7
US
H
Healthcare Trust Of America Inc
F:HT01
65.8
N/A N/A
US
Healthcare Realty Trust Inc
NYSE:HR
Negative Multiple: -16 N/A N/A
US
Sabra Health Care REIT Inc
NASDAQ:SBRA
28
18%
1.6
BE
Aedifica NV
XBRU:AED
15.3
8%
1.9

See Also

Summary
THRL intrinsic value, competitors valuation, and company profile.
DCF Valuation
THRL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
THRL stock valuation using valuation multiples.
Wall Street Estimates
THRL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
THRL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 308,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.